Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $3.67 | Change: +$0.42 | %Change: +12.92%
Volume: 24,154 | Day High/Low: 3.67/3.26 | 52 Week High/Low: 5.73/1.58


View modes: 
5 stars

RE:RE:Xartemis Approval

The approval by FDA was given over the objections of at least twenty states Attorneys General. Their concern is that this formulation will be no less addictive and perhaps easier to obtain in the...read more
0 stars

RE:Xartemis Approval

And just to prove that it isn't just a Nuvo thing - Mallinckrodt's stock is current off $1.50/share on the  FDA approval news; go figure!  rate and reply
0 stars

Xartemis Approval

Not sure to jump for joy or be disappointed that Mallinckrodt's new drug was approved today. At least they have a reason to keep all those new sales reps around even if Pennsaid 2% will fall further...read more
0 stars

RE:SYNERA HOME USE APPROVED

How material can it be if the company doesn't announce the approval. Event the Synera home page still carries this warning... SYNERA® is not for home use by patient. I understand the potential for...read more
5 stars

RE:RE:SYNERA HOME USE APPROVED

From the NRI News release regarding the Synera del with Galen: "Under the terms of the agreement, Galen has made an upfront payment to Nuvo of US$4.5 million. Nuvo will receive royalties of 10% of...read more
0 stars

RE:SYNERA HOME USE APPROVED

It is great news but just what percentage comes back to NRI as US rights sold as a way of getting cash to tide them over to Galen  from Ireland. Should be a cash cow if it"s used for off label pain...read more
5 stars

SYNERA HOME USE APPROVED

Synera has now been approved by the FDA for home use.  Prior to the approval this product was only available to practitioners for use in their offices.  With this approval Synera can now be prescribed...read more
5 stars

Nuvo Research V. Mallinckrodt Pennsaid 2% Dispute Trial Case

Sorry, one more re-post, with formatting for easier readability (new stockhouse is quirky for cut, paste and formatting):   NRI vs MNK is setting up like David versus Goliath. My editorial take on...read more
5 stars

RE:Nuvo Research v. Mallinckrodt , Pennsaid 2% Contract Dispute

Thanks Shaff for the info, always appreciated!!  rate and reply
5 stars

Nuvo Research v. Mallinckrodt , Pennsaid 2% Contract Dispute

NRI vs MNK is setting up like David versus Goliath. My editorial take on some recent developments of this ongoing dispute: a) Nuvo has switched to a smaller law firm that seems to be zealous for trial...read more
5 stars

Nuvo Research v. Mallinckrodt , Pennsaid 2% Contract Dispute

NRI vs MNK is setting up like David versus Goliath. My editorial take on some recent developments of this ongoing dispute: a) Nuvo has switched to a smaller law firm that seems to be zealous for trial...read more
0 stars

RE:Xartemis XR

What I found interesting is that additional information was sent to the FDA prior to the delay - almost exactly what happened with Pennsaid. We never did find out why there was the additional delay...read more
5 stars

Xartemis XR

After having its FDA decision delayed a few months ago, Xartemis XR (Mallinckrodt's pain drug) was supposed to get an answer by the end of February.  The market is now open on March 3rd, and there...read more
5 stars

Mallinkrodt Defence

Could one kind contributor provide the connection to the Mall defence submission!! Thank you in anticipation.  rate and reply
2 stars

RE:RE:RE:RE:RE:Peensaid 2% vs Voltaren Gel

Back at you overflowing  rate and reply
2 stars

RE:RE:RE:RE:Peensaid 2% vs Voltaren Gel

C99 and Schaff- I sent you messages.  rate and reply
4 stars

RE:Pennsaid 2% Gel or otherwise, the MNK Symantics Counterclaim

Good points. Cucumber green ah? Sweat. Have a drink for me  rate and reply
3 stars

RE:RE:RE:Peensaid 2% vs Voltaren Gel

Welcome overflowing No I haven't read it yet - do you have a link to it? I have been too busy to search it out. If the ghist of their defense is that 2% isn't a gel - well let's start counting the...read more
4.5 stars

Pennsaid 2% Gel or otherwise, the MNK Symantics Counterclaim

The P2% Gel patent is very clear on the viscosity range of the formulation. It is between 500cps and 5000cps (centipoise). The very capable and careful U.S. Patent Office finds no difficulty assigning...read more
4 stars

RE:Not a Gel!

It is somewhere between a total liquid (original Pennsaid) and a gel. It is thick enough that you can hold two pumps in your palm, which is good enough in my opinion.  Point is, Mallinckrodt isn't...read more